106 related articles for article (PubMed ID: 35913012)
41. ARID1A regulates E-cadherin expression in colorectal cancer cells: a promising candidate therapeutic target.
Erfani M; Zamani M; Hosseini SY; Mostafavi-Pour Z; Shafiee SM; Saeidnia M; Mokarram P
Mol Biol Rep; 2021 Oct; 48(10):6749-6756. PubMed ID: 34424445
[TBL] [Abstract][Full Text] [Related]
42. Silencing of microRNA-3175 represses cell proliferation and invasion in prostate cancer by targeting the potential tumor-suppressor SCN4B.
Huang H; Qing XY; Zhou Q; Li HD; Hu ZY
Kaohsiung J Med Sci; 2021 Jan; 37(1):20-26. PubMed ID: 32833340
[TBL] [Abstract][Full Text] [Related]
43. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.
Karicheva O; Rodriguez-Vargas JM; Wadier N; Martin-Hernandez K; Vauchelles R; Magroun N; Tissier A; Schreiber V; Dantzer F
Oncotarget; 2016 Sep; 7(39):64109-64123. PubMed ID: 27579892
[TBL] [Abstract][Full Text] [Related]
44. MTA1-activated Epi-microRNA-22 regulates E-cadherin and prostate cancer invasiveness.
Dhar S; Kumar A; Gomez CR; Akhtar I; Hancock JC; Lage JM; Pound CR; Levenson AS
FEBS Lett; 2017 Mar; 591(6):924-933. PubMed ID: 28231399
[TBL] [Abstract][Full Text] [Related]
45. Prostate Transglutaminase (TGase-4) Induces Epithelial-to-Mesenchymal Transition in Prostate Cancer Cells.
Ablin RJ; Owen S; Jiang WG
Anticancer Res; 2017 Feb; 37(2):481-487. PubMed ID: 28179293
[TBL] [Abstract][Full Text] [Related]
46. [Role of long noncoding RNA SNHG3 in regulating proliferation, migration and invasion of cervical cancer SiHa cells].
Sun Z; Hu J; Hu K; Tang M; Sun S; Fang Y; Yu H; Zhang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jun; 41(6):931-936. PubMed ID: 34238747
[TBL] [Abstract][Full Text] [Related]
47. N-cadherin gene expression in prostate carcinoma is modulated by integrin-dependent nuclear translocation of Twist1.
Alexander NR; Tran NL; Rekapally H; Summers CE; Glackin C; Heimark RL
Cancer Res; 2006 Apr; 66(7):3365-9. PubMed ID: 16585154
[TBL] [Abstract][Full Text] [Related]
48. MiR-363-3p promotes prostate cancer tumor progression by targeting Dickkopf 3.
Xu LZ; Ning JZ; Ruan Y; Cheng F
J Clin Lab Anal; 2022 Apr; 36(4):e24360. PubMed ID: 35303365
[TBL] [Abstract][Full Text] [Related]
49. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
Ma T; Chen H; Wang P; Yang N; Bao J
Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
[No Abstract] [Full Text] [Related]
50. Effects of miR-200c on the migration and invasion abilities of human prostate cancer Du145 cells and the corresponding mechanism.
Shi R; Xiao H; Yang T; Chang L; Tian Y; Wu B; Xu H
Front Med; 2014 Dec; 8(4):456-63. PubMed ID: 25363395
[TBL] [Abstract][Full Text] [Related]
51. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
[TBL] [Abstract][Full Text] [Related]
52. Valproic acid inhibits prostate cancer cell migration by up-regulating E-cadherin expression.
Zhang L; Wang G; Wang L; Song C; Wang X; Kang J
Pharmazie; 2011 Aug; 66(8):614-8. PubMed ID: 21901986
[TBL] [Abstract][Full Text] [Related]
53. Matrix metalloproteinase-7 induces E-cadherin cleavage in acid-exposed primary human pharyngeal epithelial cells via the ROS/ERK/c-Jun pathway.
Im NR; Kim B; Jung KY; Baek SK
J Mol Med (Berl); 2022 Feb; 100(2):313-322. PubMed ID: 34973082
[TBL] [Abstract][Full Text] [Related]
54. SNAI1 is critical for the aggressiveness of prostate cancer cells with low E-cadherin.
Deep G; Jain AK; Ramteke A; Ting H; Vijendra KC; Gangar SC; Agarwal C; Agarwal R
Mol Cancer; 2014 Feb; 13():37. PubMed ID: 24565133
[TBL] [Abstract][Full Text] [Related]
55. Ghrelin inhibits interleukin-8 production induced by hydrogen peroxide in A549 cells via NF-kappaB pathway.
Hou Y; An J; Hu XR; Sun BB; Lin J; Xu D; Wang T; Wen FQ
Int Immunopharmacol; 2009 Jan; 9(1):120-6. PubMed ID: 19038366
[TBL] [Abstract][Full Text] [Related]
56. [miR-101 inhibits the proliferation and migration of breast cancer cells via downregulating the expression of DNA methyltransferase 3a].
Liu J; Pang Y; Wang H; Li Y; Sun X; Xu F; Ren H; Liu D
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):299-303. PubMed ID: 26927545
[TBL] [Abstract][Full Text] [Related]
57. Ubiquitin C-terminal hydrolase-L1 increases cancer cell invasion by modulating hydrogen peroxide generated via NADPH oxidase 4.
Kim HJ; Magesh V; Lee JJ; Kim S; Knaus UG; Lee KJ
Oncotarget; 2015 Jun; 6(18):16287-303. PubMed ID: 25915537
[TBL] [Abstract][Full Text] [Related]
58. Down-regulation of TWIST decreases migration and invasion of laryngeal carcinoma Hep-2 cells by regulating the E-cadherin, N-cadherin expression.
Yu L; Li HZ; Lu SM; Tian JJ; Ma JK; Wang HB; Xu W
J Cancer Res Clin Oncol; 2011 Oct; 137(10):1487-93. PubMed ID: 21822911
[TBL] [Abstract][Full Text] [Related]
59. E-cadherin promotes proliferation of human ovarian cancer cells in vitro via activating MEK/ERK pathway.
Dong LL; Liu L; Ma CH; Li JS; Du C; Xu S; Han LH; Li L; Wang XW
Acta Pharmacol Sin; 2012 Jun; 33(6):817-22. PubMed ID: 22543706
[TBL] [Abstract][Full Text] [Related]
60. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
